Product logins

Find logins to all Clarivate products below.


Coronary Artery Bypass Graft Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2016

The European CABG device market consists of sales of ONCABOPCABEVH, and anastomosis assist devices used for surgical revascularization for CAD patients; ONCABdevices are also employed in open surgical heart valve procedures performed in isolation or concomitantly with CABG surgeries. This market is highly mature and faces challenges stemming from competing treatment options and increasing cost consciousness among health care facilities.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the CABG device market in Europe, including country-level data for 21 major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…
Report
Cardiac Assist Devices – Market Insights – Europe
The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient…